KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Synopsys (SNPS) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Synopsys (SNPS) over the last 16 years, with Oct 2024 value amounting to $123.2 million.

  • Synopsys' Capital Expenditures fell 3.51% to $38.6 million in Q3 2025 from the same period last year, while for Jul 2025 it was $139.3 million, marking a year-over-year decrease of 18.95%. This contributed to the annual value of $123.2 million for FY2024, which is 35.05% down from last year.
  • Latest data reveals that Synopsys reported Capital Expenditures of $123.2 million as of FY2024, which was down 35.05% from $189.6 million recorded in FY2023.
  • In the past 5 years, Synopsys' Capital Expenditures ranged from a high of $189.6 million in FY2023 and a low of $93.8 million during FY2021.
  • Its 3-year average for Capital Expenditures is $149.8 million, with a median of $136.6 million in 2022.
  • As far as peak fluctuations go, Synopsys' Capital Expenditures tumbled by 39.40% in 2021, and later spiked by 45.67% in 2022.
  • Yearly analysis of 5 years shows Synopsys' Capital Expenditures stood at $154.7 million in 2020, then plummeted by 39.40% to $93.8 million in 2021, then skyrocketed by 45.67% to $136.6 million in 2022, then skyrocketed by 38.82% to $189.6 million in 2023, then crashed by 35.05% to $123.2 million in 2024.